India carries one of the heaviest diabetic neuropathy burdens in the world. With approximately 69 million people living with diabetes, India ranks second globally in total diabetic population, and peripheral neuropathy affects an estimated 30 to 50 percent of people with long-standing diabetes. Diabetic neuropathy reduces or eliminates the protective sensation that normally alerts the foot to injury, heat, pressure, and infection. When the warning system is gone, minor problems become major ones quietly and quickly. Foot ulcerations, infections, and amputations are common complications associated with diabetes, representing major causes of morbidity and mortality. Approximately 34 percent of people with diabetes will develop foot ulcers at some point in their lives. Of those who do, approximately 20 percent will not heal within one year, and the recurrence rate within that period is approximately 40 percent.
This guide covers what diabetic neuropathy does to the foot, the full range of diabetic neuropathy treatment options in India, and the evidence-based foot care practices that prevent these statistics from applying to you.
What Diabetic Neuropathy Does to the Foot
Understanding the mechanism of neuropathic foot complications is the starting point for preventing them. Diabetic peripheral neuropathy is not a single condition. It disrupts three overlapping nervous system components, each of which contributes to foot risk in a distinct way.
The Three Components of Peripheral Neuropathy
Sensory neuropathy is the most clinically significant component for foot risk. Loss of protective sensation means patients cannot feel pressure from a poorly fitting shoe, a stone inside a sock, a blister forming on a toe, or the heat from a hot surface. Injuries that would be immediately painful in a person with intact sensation go unnoticed for hours or days, allowing infection to establish before the patient is aware anything has happened.
Motor neuropathy affects the small intrinsic muscles of the foot, causing characteristic deformities including claw toes, hammer toes, and Charcot foot deformity. These structural changes create abnormal pressure points where the skin bears concentrated load with each step, leading to callus formation and eventually skin breakdown. Autonomic neuropathy reduces sweating in the foot, causing dry, cracked skin that loses its natural protective barrier. The resulting fissures, particularly at the heels, are entry points for bacterial infection. Autonomic neuropathy also affects vascular tone, contributing to the altered blood flow patterns seen in the neuropathic foot.
The Compounding Effect of Peripheral Artery Disease
Many patients with diabetic neuropathy also have peripheral artery disease (PAD), which reduces blood supply to the foot independently of nerve damage. The combination of reduced sensation and reduced circulation creates what is called a neuroischaemic foot, where wounds heal slowly even when they are identified and treated promptly. Infection can proceed rapidly in the neuroischaemic extremity, often without signs or symptoms commensurate with its severity.
Diabetic Neuropathy Treatment in India: The Core Approaches
Diabetic neuropathy treatment addresses the condition at multiple levels simultaneously: controlling the underlying diabetes to prevent further nerve damage, managing the pain and functional consequences of existing neuropathy, and preventing the foot complications that are neuropathy's most serious outcome.
Glycaemic Optimisation: The Foundation of Every Approach
The single most important intervention for preventing neuropathy progression is long-term blood glucose control. Intensive glycaemic management with an HbA1c target of below 7 percent significantly slows the progression of diabetic peripheral neuropathy and reduces the risk of new complications in type 1 and type 2 diabetes.
At India's leading diabetology centres, glycaemic optimisation is personalised: a patient with hypoglycaemia unawareness due to autonomic neuropathy requires a different HbA1c target than a younger patient with intact hypoglycaemia awareness. SGLT2 inhibitors and GLP-1 receptor agonists, now established as cardiorenal protective agents in diabetes, are also part of comprehensive glycaemic regimens at India's advanced diabetology units.
Pharmacological Pain Management
Painful diabetic neuropathy, characterised by burning, shooting, or electric pain in the feet and legs, typically at night, significantly impairs sleep and quality of life. Two drug classes have the strongest evidence for neuropathic pain and are endorsed by the ADA 2025 Standards of Care:
-
Duloxetine (an SNRI antidepressant): first-line treatment for painful diabetic neuropathy with the strongest evidence base across multiple guidelines
-
Pregabalin and gabapentin (alpha-2 delta ligands): first or second-line options, particularly effective for the burning and shooting pain characteristic of small fibre neuropathy
Second-line and adjunct options include tricyclic antidepressants (amitriptyline, nortriptyline), tramadol for breakthrough pain, and topical agents including capsaicin cream and lidocaine patches for localised neuropathic pain without systemic side effects.
Opioids are generally reserved as a last resort given their limited long-term efficacy and significant addiction potential. The ADA guidelines advise that opioids should not be used as first or second-line agents for painful diabetic neuropathy.
Neurovascular Management
At India's diabetic foot centres, assessment of the peripheral vasculature is conducted alongside neuropathy management. Ankle-Brachial Index (ABI) measurement screens for PAD, and Doppler arterial studies characterise flow patterns in the tibial vessels. Patients with combined neuropathy and significant PAD may require vascular surgery referral for revascularisation before wound healing can be achieved.
Physical Therapy and Exercise
Structured therapeutic exercise improves peripheral blood flow, reduces neuropathic pain, and maintains the functional capacity of motor-affected muscles. A physiotherapy programme targeting foot and ankle strengthening, balance training, and gait correction reduces abnormal loading patterns that drive callus formation and skin breakdown. Exercise is one of the few interventions with evidence for slowing sensory nerve decline in addition to improving pain outcomes.
Foot Complication Prevention: The Evidence-Based Protocol
Preventing diabetic foot complications requires consistent application of a structured daily foot care protocol. The International Working Group on the Diabetic Foot (IWGDF) prevention guidelines, adapted by national bodies including the Australian Diabetes Society and India's own clinical diabetes organisations, provide the evidence base for this protocol.
Daily Foot Inspection
Every person with diabetic neuropathy should inspect the entire foot surface daily, including between the toes and the sole. Key things to look for:
-
Any new redness, warmth, or swelling
-
Skin breaks, blisters, or cracks, however small
-
Changes in callus distribution or thickness
-
Nail changes including ingrowing nails, thickened nails, or fungal discolouration
-
Any area of skin that looks different from the surrounding skin
If self-inspection is limited by mobility or vision, a mirror can be used for the sole, or a family member can assist. If any abnormality is identified, medical assessment that day is required — not the next scheduled appointment.
Footwear Selection
Inappropriate footwear is the most common precipitating cause of foot ulceration in people with diabetic neuropathy. Because sensation is reduced, patients cannot feel a poorly fitting shoe until tissue damage has already occurred.
Key footwear principles:
-
Never walk barefoot, inside the house or outside
-
Inspect the inside of shoes before putting them on every time
-
Wear shoes that fit the width and length of the foot without pressure points
-
Avoid pointed shoes, high heels, and open-toed sandals
-
Therapeutic footwear with custom insoles that redistribute pressure is indicated for patients with foot deformities or prior ulceration
Wound Care for Active Ulcers
When a foot ulcer develops, the management framework has three concurrent priorities: offloading the wound from pressure, managing infection, and promoting wound healing.
Offloading is the most important single intervention for neuropathic ulcer healing. Total contact casting (TCC) is the gold standard, distributing weight across the entire plantar surface and removing pressure from the ulcer site. Irremovable cast walkers are an evidence-supported alternative. Simply recommending rest without formal offloading is insufficient for plantar neuropathic ulcers.
Infection management in the diabetic foot requires prompt identification of the infecting organism through wound swab or tissue biopsy and appropriate antibiotic therapy. Deep infections or osteomyelitis (bone infection, which occurs in approximately 20 percent of infected diabetic foot ulcers) require intravenous antibiotics and often surgical debridement. The ADA 2026 Standards of Care confirm that infection is usually the final precipitating cause of lower-extremity amputations.
Advanced wound care for slow-healing ulcers includes debridement of non-viable tissue, negative pressure wound therapy (NPWT) for cavity wounds, bioengineered skin substitutes, and growth factor applications. India's leading diabetic foot units have access to all of these modalities, and their application under specialist supervision significantly improves healing rates compared to standard wound care alone.
The Charcot Foot: A Specific Emergency
Charcot neuropathic osteoarthropathy is one of the most dangerous complications of diabetic neuropathy and one of the most frequently misdiagnosed. It presents as a warm, swollen foot without obvious trauma, often mistaken for cellulitis or deep vein thrombosis. The underlying process involves uncontrolled bone destruction driven by abnormal autonomic vascular regulation, leading to fractures and joint dislocations that collapse the foot architecture.
Early Charcot foot requires immediate non-weight-bearing immobilisation to prevent progressive deformity. Delayed diagnosis leads to a rocker-bottom foot deformity that creates abnormal pressure points and dramatically increases ulceration risk. Any diabetic patient with an acutely warm, swollen foot, even without pain, should have urgent orthopaedic and podiatric assessment.
Accessing Diabetic Neuropathy Treatment in India
India's leading diabetology and diabetic foot centres offer comprehensive neuropathy management within a multidisciplinary team structure that integrates diabetologists, neurologists, vascular surgeons, podiatrists, orthopaedic surgeons, and wound care nurses. This multidisciplinary model reflects the ADA's recommendation that advanced diabetic foot complications are best managed in an interprofessional manner.
Key services available at India's NABH-accredited diabetes centres:
-
Comprehensive neuropathy assessment including nerve conduction studies, monofilament testing, and vibration perception threshold
-
Ankle-brachial index and Doppler vascular studies
-
Glycaemic optimisation with CGM (continuous glucose monitoring) support
-
Pharmacological neuropathic pain management
-
Total contact casting and custom offloading footwear
-
Wound care with NPWT, bioengineered skin substitutes, and hyperbaric oxygen where indicated
-
Orthopaedic and vascular surgery for Charcot reconstruction and arterial revascularisation
For international patients from Nigeria, Bangladesh, Kenya, or the UAE, where equivalent specialist diabetic foot care is either unavailable or prohibitively expensive, India's diabetic foot centres offer full diagnostic and treatment capability at 60 to 70 percent lower cost than the USA or UK.
How Karetrip Connects International Diabetic Neuropathy Patients to the Right Centre in India
Diabetic neuropathy foot complications require a multidisciplinary team, not a single specialist. Karetrip reviews each patient's diabetes history, neuropathy assessment, wound status, and vascular assessment before recommending a diabetic foot centre in India, confirming the proposed team includes diabetology, podiatry, vascular surgery, and wound care capability within the same programme.
From pre-travel medical record review and medical visa coordination, through accommodation near the treating centre and discharge documentation for diabetes management continuity at home, Karetrip manages the full international patient journey for diabetic neuropathy treatment in India.
Chat with our Medical care assistant, RUA, for quick guidance and support and take the first step toward expert diabetic foot care and neuropathy management in India.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Diabetic neuropathy and foot complications require evaluation and management by qualified medical professionals. Never adjust diabetes medications or delay foot wound assessment without medical guidance.